Konstantinos Alataris

Konstantinos Alataris

Direktor/Vorstandsmitglied bei ORYZON GENOMICS S.A.
Health Technology
Finance
Consumer Services

Profil

Konstantinos Alataris was the founder of Nevro Corp., serving as President, Chief Executive Officer & Director from 2006 to 2011.
Dr. Alataris is also the founder of Vorso Corp.,Nesos, Inc. Dr. Alataris is currently the Chairman of Invicta Medical, Inc. and will serve as Independent Director at Oryzon Genomics SA starting in 2025.
Former positions include President & Chief Executive Officer at ZP Opco, Inc. from 2016 to 2017, President, CEO, COO, CFO & Treasurer at J.E.M.
Capital, Inc. in 2016, President, Chief Executive Officer, COO & Director at Zosano Pharma Corp.
from 2016 to 2017, Executive Chairman at Irras AB from 2013 to 2015, Investment Analyst at Ventana Global Ltd. from 1998 to 1999, Head-Digital Healthcare Strategy at MC10, Inc. in 2015, and Vice President at Bay City Capital LLC.
Education includes graduate, MBA, and doctorate degrees from the University of Southern California, and an undergraduate degree from the National Technical University of Athens.

Aktive Positionen von Konstantinos Alataris

UnternehmenPositionBeginn
ORYZON GENOMICS S.A. Direktor/Vorstandsmitglied 28.02.2025
Gründer -
Vorsitzender -

Ehemalige bekannte Positionen von Konstantinos Alataris

UnternehmenPositionEnde
ZOSANO PHARMA CORPORATION Vorstandsvorsitzender 08.05.2017
Vorstandsvorsitzender 08.05.2017
J.E.M. CAPITAL INC Vorstandsvorsitzender 14.11.2016
Corporate Officer/Principal 01.07.2015
IRRS ABNPV Vorsitzender 01.06.2015
Sehen Sie sich die Erfahrung von Konstantinos Alataris im Detail an

Ausbildung von Konstantinos Alataris

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

22

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen14

Miscellaneous

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Börse
  2. Insiders
  3. Konstantinos Alataris